Approval Surge: 32 Products Pass Consistency Evaluation, Including 4 First-to-File Generics by Qilu Pharma, Nanjing Chia Tai Tianqing, and Shijiazhuang Siyao
Qilu Pharmaceutical
Specialty Formulations and Active Pharmaceutical Ingredients (API) Developer
NJCTTQ
Major Pharmaceutical R&D Company
Shijiazhuang No.4 Pharmaceutical Co.,Ltd.
Manufacturers and Service Providers of Chemical Drugs and Traditional Chinese Medicine
Today, according to the delivery information of the NMPA's drug approval certificates, 32 varieties(46 Specifications)Latest approval, involvingQilu Pharmaceutical, Chia-Tai Tianqing, Shijiazhuang No.4 Pharmaceutical Co., Ltd.and other pharmaceutical companies.
The star exclusive variety besieged by numerous companiesAvatrombopag Maleate TabletsTheThe first generic drug has been determined,Chia-TaiTianqing has taken it. In addition,Thioctic Acid Tablets, Avatrombopag Maleate Tablets, Lidocaine Hydrochloride Gel, Landiolol Hydrochloride for InjectionFour varieties have received their first approval.
Sodium Hyaluronate Eye Drops, Urapidil Hydrochloride InjectionTwo companies passed the evaluation on the same day. For more evaluation results,See the table and mini-program below for details.
12.01 Approved Varieties (Marked in Red for the First Approval)
Data Source:PharmCube Approved Drugs Summary Database
END
Reply to the keyword "Report", access dozens of exclusive reports produced by Yaorongyun
Reply to the keyword "CSCO", Obtain 2023 CSCO Guidelines
Reply to the keyword "ASCO", Obtain 2023 ASCO Abstract by Cancer Type
Reply to the keyword "First Generic in 2022", Obtain the List of First Generic Drugs Approved in 2022
Reply to the keyword "Medical Insurance", Obtain the 2022 Medical Insurance Catalog
Contact us to experience more professional services from PharmaCloud. | ||||
WillDiscussion CombinedTo | GardenDistrict TakeWu | Database Consultation | Customized Service | Media Cooperation |
